Naba Al Saha Medical Services Company NOMU
9546.SR · Healthcare · · SAR
Nomu Parallel Market
QI Only
- This is a Nomu Parallel Market stock.
- Daily price limit: ±30% (vs ±10% on the Main Market).
- Restricted to Qualified Investors only.
- Lower liquidity increases execution risk — expect wider bid-ask spreads.
Fahodi Score SELL Long-term (Investment)
48
/ 100
Technical
22
Trend & RS
24
Momentum
35
Fundamental
72
Macro
73
Liquidity
8
| Component | Score | Weight |
|---|---|---|
| Technical | 22.5 | 10% |
| Trend & RS | 23.5 | 10% |
| Momentum | 34.7 | 5% |
| Fundamental | 72.2 | 40% |
| Macro | 72.8 | 15% |
| Liquidity | 8.3 | 20% |
Trade Setup
| Entry | 45.02 |
| Stop Loss | 42.68 (5.2%) |
| Target 1 (1:1) | 47.36 (+5.2%) |
| Target 2 (2:1) | 49.70 (+10.4%) |
| ATR(14) | 1.17 (2.6%) |
| Risk per Share | 2.34 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 71.4 | +0.86 | |
| Momentum | 34.7 | -0.61 | |
| Quality | 64.4 | +0.58 | |
| Composite | 56.9 | ||
Quality Scores
Piotroski F-Score
6
/9 —
Average
✓
✓
✗
✗
✓
✓
✗
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
3.89
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 17.2 | 22.0 | -22% below |
| P/B Ratio | 2.1 | 4.0 | Below |
| Dividend Yield | 70.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
25.87
vs
Market Price
45.02
Upside
-42.5%
| Margin of Safety | -74.0% |
| Stage 1 PV (5yr FCF) | 93,059,560 |
| Terminal Value PV | 178,615,466 |
| Total Enterprise Value | 271,675,026 |
Assumptions
| Base FCF | 22,008,000 |
| Growth Rate (5yr) | 5.8% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 12.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
2.7%
Recommended Size
30.87%
Full Kelly
15.44%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 48/100. Estimated win rate 54%, avg win 7.9%, avg loss 4.0%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
BEAR
Regime: BEAR (20% confidence) — position size reduced 10%
Nomu Liquidity Adjustment: Position size reduced 40% for Nomu Parallel Market liquidity risk (thin order books, wider spreads, ±30% daily limit).
Signal Summary STRONG SELL
1
Bullish Signals
3
Bearish Signals
48.37
RSI(14)
-0.1943
MACD
Relative Strength (RS) WEAK RS
21
/ 99
RS Rating
O'Neil filter: <80
| RS vs TASI | ↓ FALLING (-4.5% vs TASI 3M) |
| RS vs Sector | INLINE (Healthcare) |
| RS New High | No (56d since high) |
| Sector Outperformance | +6.6% (3M) |
RS Line — stock / TASI (90 bars)
← older
newer →
RS vs TASI
50-day SMA of RS
WEAK RS:
Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 48.37 | NEUTRAL |
| Macd | -0.1943 | BULLISH |
| Ma Cross | 45.09 / 53.69 | DEATH CROSS |
| Trend Short | BELOW SMA50 | |
| Trend Long | BELOW SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.02x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 69.70 |
| Bollinger Upper | 46.28 |
| SMA(200) | 53.69 |
| SMA(50) | 45.09 |
| SMA(20) | 45.01 |
| Current Price | 45.02 |
| Bollinger Lower | 43.73 |
| 52-Week Low | 40.74 |
| ATR(14) | 1.17 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
ACCUMULATION A
Confidence
100%
Selling Climax
Acc: 2.0 |
Dist: 0.0 |
Markup: 0.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-05-06 | Normal | 0.02x | Normal bar — no special VSA pattern |
| 2026-05-07 | No Demand | 0.32x | Low volume, narrow spread, weak close — no buying interest |
| 2026-05-10 | Stopping Volume | 3.34x | High volume down-bar closing near low — potential climax (Stopping Volume) |
| 2026-05-11 | Normal | 0.03x | Normal bar — no special VSA pattern |
| 2026-05-12 | Normal | 0.02x | Normal bar — no special VSA pattern |
Ichimoku Cloud BEARISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 46.33 | Above Kijun |
| Kijun-sen (26) | 45.75 | Base line |
| Senkou A | 46.04 | Leading span A |
| Senkou B | 48.97 | Leading span B |
| Cloud | 46.04 – 48.97 | Bearish (Red) |
| Price vs Cloud | 45.02 | Below Cloud |
| Chikou Span | 48.00 | Bearish |
| Alignment Score | 1/4 | BEARISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BEARISH
BB: 43.73 – 46.28 | KC: 43.84 – 46.18
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 45.28
Anchor: 2026-03-04 (52w Low)
BELOW AVWAP
-0.6%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/9546.SR
Valuation
| Metric | Value |
|---|---|
| Market Cap | 472.71M |
| P/E (TTM) | 17.18 |
| Forward P/E | N/A |
| P/B | 2.12 |
| EPS | 2.62 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 5.8% |
| Profit Margin | 13.6% |
| ROE | 13.0% |
| Debt/Equity | 55.11 |
| Current Ratio | 6.26 |
| Dividend Yield | 70.0% |
| Payout Ratio | N/A |
| Beta | -0.49 |
Trading Data
45.02
Open
45.02
Day High
45.02
Day Low
43.00
Volume (0.0x avg)
Insider Activity
Insider transaction data is not available for Saudi-listed stocks.
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)